Amandala Neuro
- Founded
- 2025
- Business Model
- B2B
- Website
- amandalaneuro.com
- Last Round
- Seed
- Rounds
- 1
About
Clinical-stage biopharmaceutical company spun from Beckley Psytech and Atai Life Sciences, developing short-acting psychedelic treatments for psychiatric disorders.
Summary
Amandala Neuro is a Biotech company, founded in 2025. Investors include FJ Labs.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Unknown
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...